Arkadios Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.16M Buy
86,000
+6,456
+8% +$306K 0.05% 371
2025
Q4
$4.05M Buy
79,544
+46,743
+143% +$2.39M 0.08% 263
2025
Q3
$1.82M Sell
32,801
-1,989
-6% -$116K 0.04% 427
2025
Q2
$2.4M Buy
34,790
+20,397
+142% +$1.39M 0.07% 299
2025
Q1
$999K Sell
14,393
-3,011
-17% -$249K 0.04% 456
2024
Q4
$1.5M Sell
17,404
-1,358
-7% -$147K 0.08% 242
2024
Q3
$2.23M Sell
18,762
-283
-1% -$37.7K 0.13% 169
2024
Q2
$2.72M Buy
19,045
+5,178
+37% +$686K 0.18% 117
2024
Q1
$1.78M Buy
13,867
+3,222
+30% +$384K 0.14% 159
2023
Q4
$1.1M Buy
10,645
+6,974
+190% +$690K 0.09% 204
2023
Q3
$334K Sell
3,671
-9
-0.2% -$793 0.03% 453
2023
Q2
$298K Sell
3,680
-276
-7% -$22.5K 0.03% 448
2023
Q1
$315K Buy
3,956
+498
+14% +$35.3K 0.04% 423
2022
Q4
$234K Buy
+3,458
New +$203K 0.03% 474
2021
Q4
Sell
-268
Closed -$12K 1362
2021
Q3
$12K Sell
268
-48
-15% -$2.32K ﹤0.01% 1394
2021
Q2
$13K Buy
316
+256
+427% +$9.92K ﹤0.01% 1457
2021
Q1
$2K Sell
60
-348
-85% -$12.4K ﹤0.01% 1534
2020
Q4
$14K Buy
+408
New +$14.1K ﹤0.01% 868
2020
Q2
Sell
-204
Closed -$6.14K 1079
2020
Q1
$6.14K Buy
+204
New +$6.07K ﹤0.01% 743

Other funds holding NVO

Arkadios Wealth Advisors's NVO Position: Q1 2026 in Review

Arkadios Wealth Advisors increased its Novo Nordisk (NVO) stake by 8.1% in Q1 2026, buying an estimated $306K and bringing the position to 86,000 shares worth $3.16M. The position accounts for 0.05% of the portfolio, ranked #371.

Arkadios Wealth Advisors first reported a position in NVO in Q1 2020 and has held it in 19 quarters since. The position peaked at $4.05M in Q4 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Arkadios Wealth Advisors held 86,000 shares of Novo Nordisk worth $3.16M as of Q1 2026.
  • Arkadios Wealth Advisors bought 6,456 Novo Nordisk shares in Q1 2026, an estimated $306K.
  • Novo Nordisk made up 0.05% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #371 holding.
  • Arkadios Wealth Advisors first reported a position in Novo Nordisk in Q1 2020 and has held it in 19 quarters since.
  • Arkadios Wealth Advisors's Novo Nordisk position peaked at $4.05M in Q4 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.